Novo Nordisk's pricing techniques within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of rate gouging, declaring the stark contrast in between U.S. costs and those in Europe and copyright.Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd,[3] with